Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.9608
+0.0208 (2.21%)
At close: Jul 17, 2026, 4:00 PM EDT
0.9800
+0.0192 (2.00%)
After-hours: Jul 17, 2026, 7:26 PM EDT
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $85.99 million as of July 17, 2026. Its market cap has increased by 124.96% in one year.
Market Cap
85.99M
Enterprise Value
55.32M
1-Year Change
124.96%
Ranking
Category
Stock Price
$0.96
ChartMarket Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $85.99M, a decrease of -66.47%. That is a compound annual growth rate of -20.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 85.99M | -27.84% |
| Dec 31, 2025 | 119.17M | 308.99% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
| Oct 8, 2021 | 256.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MAIA Biotechnology | 89.38M |
| Rein Therapeutics | 88.03M |
| Entera Bio | 87.74M |
| Alterity Therapeutics | 87.40M |
| NeurAxis | 86.44M |
| Rallybio | 85.46M |
| Rani Therapeutics Holdings | 83.87M |
| Telomir Pharmaceuticals | 83.22M |